Skip to content

CLINIC 6: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

CLINIC 6

BE 0564.960.563
NACE 32.500, Manufacture of medical and dental instruments and supplies
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€967
2024 · €7,557-€6,590
Equity
€131,229
2024 · €130,262+€967
Cash
€60,163
2024 · €74,589-€14,426
Balance sheet total
€357,411
2024 · €610,272-€252,860

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€226,710

    down €226,710 (-47.0%), from €482,666 to €255,956

    of which Trade receivables: -€263,159

  • Cash -€14,426

    down €14,426 (-19.3%), from €74,589 to €60,163

    mainly Trade debts (-€389,816)

  • Stocks and contracts -€9,395

    down €9,395 (-21.2%), from €44,300 to €34,905

Equity and liabilities
  • Trade debts -€389,816

    down €389,816 (-81.2%), from €480,010 to €90,194

  • Other debts +€135,988

    new in 2025: €135,988

Income statement
  • Financial income -€7,202

    no longer reported in 2025 (was €7,202)

  • Gross operating margin -€5,008

    down €5,008 (-39.1%), from €12,798 to €7,790

  • Depreciation -€3,350

    down €3,350 (-61.7%), from €5,431 to €2,081

  • Financial charges -€3,252

    down €3,252 (-47.8%), from €6,799 to €3,547

  • Other operating charges +€1,005

    up €1,005 (+527%), from €191 to €1,195

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €7,557
Gross operating margin -€5,008
Depreciation +€3,350
Other operating charges -€1,005
Financial income -€7,202
Financial charges +€3,252
Taxes +€23
Result 2025 €967
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€14,426
Investment €0
Financing €0
Cash 2024 €74,589
Net result for the year +€967
Depreciation +€2,081
Stocks and contracts +€9,395
Receivables within one year +€226,710
Deferred charges and accrued income +€249
Trade debts -€389,816
Other debts +€135,988
Cash 2025 €60,163
brings cash intakes cash out
Every line side by side 36 lines
Line Code 2024 2025 Change %
Total assets 20/58 €610,272 €357,411 -€252,860 -41.4%
Fixed assets 21/28 €6,362 €4,282 -€2,081 -32.7%
Tangible fixed assets 22/27 €6,242 €4,162 -€2,081 -33.3%
Furniture and vehicles 24 €6,242 €4,162 -€2,081 -33.3%
Financial fixed assets 28 €120 €120 = 0.0%
Current assets 29/58 €603,910 €353,130 -€250,780 -41.5%
Stocks and contracts in progress 3 €44,300 €34,905 -€9,395 -21.2%
Stocks 30/36 €44,300 €34,905 -€9,395 -21.2%
Amounts receivable within one year 40/41 €482,666 €255,956 -€226,710 -47.0%
Trade receivables 40 €477,021 €213,862 -€263,159 -55.2%
Other amounts receivable 41 €5,645 €42,094 +€36,450 +646%
Cash at bank and in hand 54/58 €74,589 €60,163 -€14,426 -19.3%
Deferred charges and accrued income 490/1 €2,355 €2,106 -€249 -10.6%
Total equity and liabilities 10/49 €610,272 €357,411 -€252,860 -41.4%
Equity 10/15 €130,262 €131,229 +€967 +0.7%
Contributions 10/11 €40,000 €40,000 = 0.0%
Reserves 13 €4,847 €4,847 = 0.0%
Distributable reserves 133 €4,847 €4,847 = 0.0%
Profit (loss) carried forward 14 €85,415 €86,382 +€967 +1.1%
Amounts payable 17/49 €480,010 €226,182 -€253,828 -52.9%
Amounts payable within one year 42/48 €480,010 €226,182 -€253,828 -52.9%
Trade debts 44 €480,010 €90,194 -€389,816 -81.2%
Suppliers 440/4 €480,010 €90,194 -€389,816 -81.2%
Other amounts payable 47/48 - €135,988 +€135,988
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €5,431 €2,081 -€3,350 -61.7%
Other operating charges 640/8 €191 €1,195 +€1,005 +527%
Gross operating margin 9900 €12,798 €7,790 -€5,008 -39.1%
Operating profit (loss) 9901 €7,177 €4,514 -€2,662 -37.1%
Financial income 75/76B €7,202 - -€7,202
Recurring financial income 75 €7,202 - -€7,202
Financial charges 65/66B €6,799 €3,547 -€3,252 -47.8%
Recurring financial charges 65 €6,799 €3,547 -€3,252 -47.8%
Profit (loss) for the period before taxes 9903 €7,580 €967 -€6,613 -87.2%
Income taxes 67/77 €23 - -€23
Profit (loss) for the period 9904 €7,557 €967 -€6,590 -87.2%
Profit (loss) for the period to be appropriated 9905 €7,557 €967 -€6,590 -87.2%

Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 27 October 2026 via checked.be.